Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tPA in Acute Ischemic Stroke With or Without COVID-19
NCT05258565Phase 1Completed
- Sponsor
- Assiut University
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Assiut University. Started Mar 2022; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05258565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05258565.